Evaluating the Role of Neoadjuvant Sacituzumab Govitecan in Bladder Cancer.

Authors :: Inman, Silas
Source :: Targeted Therapies in Oncology; Jul2024, Vol. 13 Issue 9, p37-38, 2p
Publication Year :: 2024

Subjects :: THERAPEUTIC use of antineoplastic agents
BLADDER tumors
DRUG toxicity
PATIENT safety
DRUG side effects
ENZYME inhibitors
ANTINEOPLASTIC agents
TUMOR markers
GENETIC polymorphisms
DRUG approval
COMBINED modality therapy
QUALITY of life
OVERALL survival
PHARMACODYNAMICS

Tools